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Abstract
Background:  CCl4 is a well-established hepatotoxin inducing liver injury by producing free
radicals. Exposure to CCl4 also induces acute and chronic renal injuries. The present study was
designed to establish the protective effect of hesperidin (HDN), a citrus bioflavonoid, on CCl4-
induced oxidative stress and resultant dysfunction of rat liver and kidney.
Methods: Animals were pretreated with HDN (100 and 200 mg/kg orally) for one week and then
challenged with CCl4 (2 ml/kg/s.c.) in olive oil. Rats were sacrificed by carotid bleeding under ether
anesthesia. Liver enzymes, urea and creatinine were estimated in serum. Oxidative stress in liver
and kidney tissue was estimated using Thiobarbituric acid reactive substances (TBARS), glutathione
(GSH) content, superoxide dismutase(SOD), and Catalase (CAT)
Results: CCl4 caused a marked rise in serum levels of ALT and AST (P < 0.05). TBARS levels were
significantly increased whereas GSH, SOD and CAT levels decreased in the liver and kidney
homogenates of CCl4 treated rats. HDN (200 mg/kg) successfully attenuated these effects of CCl4
Conclusion: In conclusion, our study demonstrated a protective effect of HDN in CCl4 induced
oxidative stress in rat liver and kidney. This protective effect of HDN can be correlated to its direct
antioxidant effect.
Background
Drug exposure, ionizing radiations and environmental
pro-oxidant pollutants induce free radical formation.
Lipid peroxidation initiated by free radicals is considered
to be deleterious for cell membranes and has been impli-
cated in a number of pathological situations. Carbontetra-
chloride (CCl4), an industrial solvent, is a well-
established hepatotoxin [1-3]. Various Studies demon-
strated that liver is not the only target organ of CCl4 and it
causes free radical generation in other tissues also such as
kidneys, heart, lung, testis, brain and blood [4-6]. It has
also been reported that exposure to CCl4 induces acute
and chronic renal injuries [7,8]. Case control studies and
various documented case reports increasingly establish
that hydrocarbon solvents produce renal diseases in
humans [9].
Extensive evidence demonstrates that as a result of the
metabolic activation of CCl4, •CCl4 and •Cl, are formed
which initiate lipid peroxidation process. Vitamin E pro-
tected CCl4-induced liver injury indicating the role of oxi-
dative stress in this model [10]. Studies also show that
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certain natural extracts containing antioxidants protect
against the CCl4-induced increased lipid peroxide levels
and impairment in hepatic GSH status [11].
Hesperidin is a flavanone glycoside abundantly found in
sweet orange and lemon and is an inexpensive by-product
of citrus cultivation [12]. Hesperidin is effectively used as
a supplemental agent in the treatment protocols of com-
plementary settings. Its deficiency has been linked to
abnormal capillary leakiness as well as pain in the extrem-
ities causing aches, weakness and night leg cramps. Sup-
plemental hesperidin also helps in reducing oedema or
excess swelling in the legs due to fluid accumulation. A
number of researchers have examined the antioxidant
activity and radical scavenging properties of hesperidin
using a variety of assay systems [13-16].
Thus the present study was designed to investigate the
effect of HDN on CCl4-induced oxidative stress and result-
ant dysfunction of rat liver and kidney.
Results
Effect on liver enzymes
CCl4 caused a marked rise in serum levels of ALT (control
= 45 IU/L) and AST (control = 135 IU/L) demonstrating a
marked liver damage. Treatment with HDN decreases the
elevated levels of ALT and AST in serum (P < 0.05)(Table
1). Both the doses of HDN also attenuated the CCl4-
induced elevated levels of total bilirubin (control = 0.184
mg/dl).
Effect on hepatic and renal TBARS levels
CCl4 challenge caused a marked lipid peroxidation in
both liver (control = 1.5 micromoles/mg protein) and
kidney (control = 33.86 nmoles/mg protein). Both the
doses of HDN decreased the level of lipid peroxidation in
liver, but in the kidney, no effect on lipid peroxidation
was seen with 100-mg/kg dose, and only the higher dose
of HDN (200 mg/kg) could attenuate the increased level
of lipid peroxidation (P < 0.05) (Fig 1). 7-day oral feeding
of HDN per se (200 mg/kg) did not result in a significant
alteration of either hepatic or renal TBARS levels.
Effect on the glutathione levels in CCl4 treated rats
CCl4  administration markedly decreased the levels of
reduced glutathione in both the liver (control = 35.99
micromoles/mg protein) and kidneys (control = 27.99
micromoles/mg protein) demonstrating oxidative stress.
HDN (200 mg/kg) per se did not produce any change in
the levels of reduced glutathione either in liver or kidney.
HDN (100 mg/kg) showed no effect on the levels of
reduced glutathione either in liver or kidney in CCl4
treated rats whereas HDN (200 mg/kg) significantly amel-
iorated CCl4-induced depletion of GSH in both liver and
kidney (P < 0.05)(Fig-2). HDN per se (200 mg/kg) did not
result in a significant alteration of either hepatic or renal
GSH levels.
Effect on the antioxidant enzymes in liver and kidneys in 
CCl4 treated Rats
CCl4 challenge significantly decreased the levels of SOD
and catalase in both liver (SOD: control = 25.66 U/mg
protein; Catalase: control = 0.32 K/min) and kidneys
(SOD: control = 99.22 U/mg protein; Catalase: control =
0.32 K/min). HDN per se (200 mg/kg) had no effect on
these enzymes either in liver or in kidneys. HDN (100 mg/
kg) failed to improve the levels of SOD or catalase either
in liver or kidneys of CCl4 administered rats but HDN
(200 mg/kg) significantly increased the levels of both
enzymes in liver and kidneys of CCl4 treated rats (P <
0.05)(Fig-3 and 4). 7-day oral feeding of HDN per se (200
mg/kg) did not result in a significant alteration of any of
these antioxidant enzymes either in liver or kidney.
Discussion
CCl4-induced lipid peroxidation is highly dependent on
its bioactivation to the trichoromethyl radical and trichlo-
romethyl peroxy radical [17-19]. It is well known that
CCl4 is activated by the cytochrome P450 system. The
initial metabolite is the trichloromethyl free radical,
which is believed to initate the biochemical events that
ultimately culminate in liver cell necrosis[20,21]. The
trichloromethyl radical can form covalent adducts with
lipids and proteins, interact with O2 to form a tricholor-
omethyl peroxy radical or abstract hydrogen atoms to
Table 1: Effect of different doses of Hesperidin on CCl4 induced rise in AST, ALT and total bilirubin.
ALT (IU/L) AST(IU/L) Bilirubin total (mg/dl)
Control 100 100 100
CCl4 255.55 ± 23.66a 444.44 ± 22.56a 205.21 ± 11.66a
HDN (200) 112.81 ± 13.66 126.66 ± 28.66 108.15 ± 9.66
CCl4+HDN (100) 185.18 ± 17.56a,b 333.33 ± 29.66a,b 176.63 ± 15.29a,b
CCl4+HDN (200) 144.44 ± 15.22a,b,c 244.44 ± 22.66a,b,c 149.45 ± 12.45a,b,c
Values are expressed as percent response compared to control rats. a = Statistical significant at P < 0.05 as compare to control, b = Statistical 
significant at P < 0.05 as compare to CCl4, c = Statistical significant at P < 0.05 as compare to CCl4+ HDN(100)BMC Pharmacology 2005, 5:2 http://www.biomedcentral.com/1471-2210/5/2
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form chloroform [22]. Other products include conjugated
dienes, lipid hydroperoxides, malonaldehyde-like sub-
stances, and other short-chain hydrocarbons [23-25]. In
response to hepatocellular injury initiated by the biotrans-
formation of CCl4 to reactive radicals, "activated" Kupffer
cells in liver respond by releasing increased amounts of
active oxygen species and other bioactive agents [26].
Protective effects of various natural products in CCl4 hepa-
totoxicity have been reported [27]. Studies done with Gin-
seng showed that the antioxidant property of ginsenosides
contributes to protection against CCl4 induced hepatotox-
icity in rats [28]. In the present study, CCl4 induced a
severe hepatic damage as represented by markedly ele-
vated levels of ALT, AST and bilirubin coupled with a
marked hepatic oxidative stress. CCl4-induced generation
of peroxy radicals and O2
-• leads to inactivation of catalase
and SOD. We too observed that CCl4 challenge signifi-
cantly decreased the levels of SOD and catalase in liver
and kidney. Recently, Szymonik-Lesiuk et al [2] have
shown that CCl4 intoxication can lead to alteration in
gene expression and depletion of SOD and catalase levels
in kidney and heart. Oxidative stress causes depletion of
intracellular GSH, leading to serious consequences. HDN
administration ameliorated the increased level of lipid
peroxidation after CCl4 treatment. Interestingly, only the
higher dose of HDN (200 mg/kg) was able to show
improvement in the levels of endogenous antioxidant
enzymes (SOD and catalase) and GSH in liver. Improve-
ment of hepatic GSH levels in HDN-treated rats in com-
parison to CCl4  intoxicated rats demonstrates the
antioxidant effect of HDN.
We failed to observe any effect of CCl4 on renal function.
Neither BUN nor serum creatinine levels increased after
CCl4 administration (data not shown). Studies by Zim-
merman et al [29] also did not report any rise in BUN lev-
els even after chronic treatment of CCl4  in
nephrectomized rats. They found an increased frequency
of glomerulosclerosis and tubulointerstitial alterations in
rats with reduced renal mass on CCl4  administration
thereby indicating nephrotoxicity on long-term CCl4
administration in rats. These findings raise the possibility
that renal disease in man is related to hydrocarbon solvent
exposure and may also be potentiated by concomitant
renal disease or impaired renal function. Ogawa et al [30]
Effect of different doses of Hesperidin on CCl4 induced lipid peroxidation in rat liver and kidney Figure 1
Effect of different doses of Hesperidin on CCl4 induced lipid peroxidation in rat liver and kidney. Values are expressed as per-
cent response compared to control rats. a = Statistical significant at P < 0.05 as compare to control, b = Statistical significant at 
P < 0.05 as compare to CCl4, c = Statistical significant at P < 0.05 as compare to CCl4+ HDN(100)
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also reported that chronic renal injuries and BUN eleva-
tions developed in Balb/c mice only after 12 weeks of
CCl4 intoxication. On the contrary, we estimated the renal
function just after 48 hrs of CCl4 challenge. Thus this brief
period might not be sufficient to demonstrate any rise in
serum BUN and creatinine levels. Though renal function
did not alter after 48 hrs of CCl4 administration but even
this short period of exposure led to a significant oxidative
stress in kidneys. Fadhel and coworkers [31] had also
reported increased levels of renal TBARS in rats after CCl4
exposure which could be improved by black tea extract.
Similar observations were also reported with certain
Indian ayurvedic Indian preparations [32].
HDN treatment has been previously demonstrated to
improve GSH levels in liver and kidneys of diabetic rats
and a decrease in levels of 8-hydroxydeoxyguanosine (8-
OHdG), a marker of DNA fragmentation, in the urine of
diabetic rats [33]. HDN in combination with Diosmin has
also been shown to inhibit the reactive oxygen radicals
production in Zymosan-stimulated human polymorpho-
nuclear neutrophils [34]. Thus HDN has been shown to
reduce oxidative stress in various in-vivo and in-vitro
studies.
Conclusions
In conclusion, our study demonstrated that CCl4 induces
a marked oxidative stress in rat liver and kidney, which is
amenable to attenuation by HDN. This protective effect of
HDN can be correlated directly to its antioxidant
property.
Methods
Animals
Male wistar rats (150 g–200 g), bred in the central animal
house of Panjab University (Chandigarh, India) were
used. The animals were housed under standard condi-
tions of light and dark cycle with free access to food (Hin-
dustan Lever Products, Kolkata, India) and water. The
experimental protocols were approved by the
Institutional Ethical Committee of Panjab University,
Chandigarh.
Effect of different doses of Hesperidin on CCl4 induced depletion in GSH levels in rat liver and kidney Figure 2
Effect of different doses of Hesperidin on CCl4 induced depletion in GSH levels in rat liver and kidney. Values are expressed as 
percent response compared to control rats. a = Statistical significant at P < 0.05 as compare to control, b = Statistical signifi-
cant at P < 0.05 as compare to CCl4, c = Statistical significant at P < 0.05 as compare to CCl4+ HDN(100)
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Drugs
Chemicals employed in these studies were reagent grade.
Carbon tetrachloride (E Merck, India) was administered
subcutaneously in olive oil Hesperidin (Sigma chemical
USA) was suspended in 0.5% sodium carboxy methyl cel-
lulose (CMC) and administered orally.
Experimental groups and protocol
Animals were divided into following groups, each con-
taining 6–8 animals: Control: These animals received a
vehicle for HDN (i.e. CMC) by oral route for eight days
and on 8th day, they were administered the subcutaneous
injection of olive oil. CCl4 group: These animals received
vehicle for 10 days and were challenged with CCl4 2 ml/
kg/s.c. (40% v/v in olive oil) on 8th day. In the preliminary
studies done in our lab, we observed a very high mortality
rate (50–60%) when CCl4 was administered interaperito-
neally. Thus we adopted the subcutaneous route of CCl4
administration as reported in the literature [35]. With this
route and dose of CCl4, the mortality rate reduced to
about 20%(1-2/8 animal) HDN group: These rats received
only HDN 200 mg/kg/p.o. daily for 10 days CCl4+ HDN
(100): Rats received HDN continuously for 8 days. On
eight day just after HDN treatment they received CCl4 2
ml/kg/s.c in olive oil. HDN was further continued for 2
more days. CCl4+ HDN (200): This group is similar to the
above one except that the dose of HDN administered was
200 mg/kg/p.o. On the 10th day, animals were sacrificed 2
hr, after the last dose of HDN and blood was collected, by
carotid bleeding, in centrifuge tubes. Serum was separated
and was used freshly for the assessment of renal and liver
function tests. Both the kidneys and the liver were quickly
harvested and immediately stored at -20°C till further
biochemical estimations.
Assessment of renal functions
Before sacrifice, rats were kept individually in metabolic
cages for 24 h to collect urine for estimation of renal func-
tion. Serum samples were assayed for blood urea nitrogen
(BUN), urea clearance, serum creatinine & creatinine
clearance by using standard diagnostic kits (Span Diag-
nostics, Gujarat, India).
Assessment of liver function
Serum alanine aminotransferase (ALT) and serum aspar-
tate aminotransferase (AST) were estimated by
Effect of different doses of Hesperidin on CCl4 induced depletion in SOD levels in rat liver and kidney Figure 3
Effect of different doses of Hesperidin on CCl4 induced depletion in SOD levels in rat liver and kidney. Values are expressed as 
percent response compared to control rats. a = Statistical significant at P < 0.05 as compare to control, b = Statistical signifi-
cant at P < 0.05 as compare to CCl4
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International Federation of Clinical Chemistry [36]
(ERBA test kits). Serum bilirubin was estimated by Diazo
method [37] (ERBA test kits).
Assessment of oxidative stress
Post mitochondrial supernatant preparation (PMS)
Kidneys and liver were, perfused with ice cold saline
(0.9% sodium chloride) and homogenized in chilled
potassium chloride (1.17%) using a homogenizer. The
homogenates were centrifuged at 800 g for 5 minutes at
4°C to separate the nuclear debris. The supernatant so
obtained was centrifuged at 10,500 g for 20 minutes at
4°C to get the post mitochondrial supernatant which was
used to assay catalase and superoxide dismutase (SOD)
activity.
Estimation of lipid peroxidation
The malondialdehyde (MDA) content, a measure of lipid
peroxidation, was assayed in the form of thiobarbituric
acid reacting substances (TBARS) by method of Okhawa
et al. [38] Briefly, the reaction mixture consisted of 0.2 ml
of 8.1% sodium lauryl sulphate, 1.5 ml of 20% acetic acid
solution adjusted to pH 3.5 with sodium hydroxide and
1.5 ml of 0.8% aqueous solution of thiobarbituric acid
was added to 0.2 ml of 10%(w/v) of PMS. The mixture
was brought up to 4.0 ml with distilled water and heated
at 95°C for 60 minutes. After cooling with tap water, 1.0
ml distilled water and 5.0 ml of the mixture of n-butanol
& pyridine (15:1 v/v) was added and centrifuged. The
organic layer was taken out and its absorbance was meas-
ured at 532 nm. TBARS were quantified using an extinc-
tion coefficient of 1.56 × 105 M-1/cm-1 and expressed as
nmol of TBARS per mg protein. Tissue protein was esti-
mated using Biuret method of protein assay and the
TBARS content expressed as nanomoles per milligram of
protein.
Estimation of reduced glutathione
Reduced glutathione (GSH) in the kidneys and liver was
assayed by the method of Jollow et al [39]. Briefly, 1.0 ml
of PMS (10%) was precipitated with 1.0 ml of sulphosal-
icylic acid (4%). The samples were kept at 4°C for at least
1 hour and then subjected to centrifugation at 1200 g for
15 minutes at 4°C. The assay mixture contained 0.1 ml
Effect of different doses of Hesperidin on CCl4 induced depletion in Catalase levels in rat liver and kidney Figure 4
Effect of different doses of Hesperidin on CCl4 induced depletion in Catalase levels in rat liver and kidney. Values are expressed 
as percent response compared to control rats. a = Statistical significant at P < 0.05 as compare to control, b = Statistical signif-
icant at P < 0.05 as compare to CCl4
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filtered aliquot and 2.7 ml phosphate buffer (0.1 M, pH
7.4) in a total volume of 3.0 ml. The yellow colour devel-
oped was read immediately at 412 nm on a
spectrophotometer.
Estimation of SOD
SOD activity was assayed by the method of Kono et al.[40]
The assay system consisted of EDTA 0.1 mM, sodium car-
bonate 50 mM and 96 mM of nitro blue tetrazolium
(NBT). In the cuvette, 2 ml of above mixture, 0.05 ml
hydroxylamine and 0.05 ml of PMS were taken and the
auto-oxidation of hydroxylamine was observed by meas-
uring the absorbance at 560 nm.
Estimation of catalase
Catalase activity was assayed by the method of Claiborne
et al [41]. Briefly, the assay mixture consisted of 1.95 ml
phosphate buffer (0.05 M, pH 7.0), 1.0 ml hydrogen per-
oxide (0.019 M) and 0.05 ml PMS (10%) in a final vol-
ume of 3.0 ml. Changes in absorbance were recorded at
240 nm. Catalase activity was calculated in terms of k
minutes-1.
Statistical analysis
Results were expressed as mean ± SEM. The intergroup
variation was measured by one way analysis of variance
(ANOVA) followed by Fischer's LSD test. Statistical signif-
icance was considered at p < 0.05. The statistical analysis
was done using the Jandel Sigma Stat Statistical Software
version 2.0.
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